APM logo

Aptorum Group Limited (APM) Company Overview

Profile

Full Name:

Aptorum Group Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

December 18, 2018

Indexes:

Not included

Website:

http://www.aptorumgroup.com

Description:

Aptorum Group Limited is a biopharmaceutical company focused on developing innovative treatments for various diseases. They work on new drugs and therapies, particularly in areas like metabolic and infectious diseases, aiming to improve patient outcomes and address unmet medical needs.

Key Details

Price

$0.95

Market Cap

$5.33 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$431.40 K(-66.71% YoY)

Annual EPS

-$0.62(+77.45% YoY)

PE Ratio

-

Annual ROE

-24.33%

Annual Debt To Equity

0.12

Beta

1.33

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Dec 20, 2024

Recent annual earnings:

Apr 30, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 23, 2023

Analyst ratings

Recent major analysts updates

Oct 7, 22 HC Wainwright & Co.
Buy
Apr 2, 19 China Renaissance
Buy

Screeners with APM included

Growing Shares Outstanding
Stocks with high beta
UK stocks
Stocks below SMA 200
Most recommended stocks
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.95
APM price is $0.95

Price All-time High

$325.50
APM price is currently -99.71% below its historical high of $325.50

Price Analysts Target

-
APM price consensus analysts' forecast is unknown

Price Most Recent Change

-5.93%
APM price was down -5.93% on Feb 28, 2025

Price YTD Change

-63.46%
APM price is down -63.46% since January 1st

Price 3-Year Change

-93.4%
APM price is down -93.4% over the past 3 years

Market cap

Market Cap

$5.33 M
APM market capitalization is $5.33 million

Market Cap 3-Year Change

-89.62%
APM market capitalization is down -89.62% over the past 3 years

Market Cap All-time High

$943.14 M
APM market capitalization is currently -99.43% below its historical high of $943.14 million

Market Cap Sector Rank

12.74%
APM market capitalization is higher than 12.74% of companies in Healthcare sector

Technical

Beta

1.33
APM beta is 1.33

200-day SMA

$2.40
APM price is currently -60.35% below its 200-day simple moving average

14-day RSI

40.25
APM 14-day relative strength index is 40.25

30-day Relative Volume

0.21
APM 30-day relative volume is 0.21

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$431.40 K
APM annual revenue is $431.40 thousand

Annual Revenue Analysts Estimate

-
APM annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-66.71%
APM annual revenue is down -66.71% year-on-year

Annual Revenue Sector Rank

9.28%
APM annual revenue is higher than 9.28% of companies in Healthcare sector

Profit

Annual Gross Profit

$10.60 K
APM annual gross profit is $10.60 thousand

Annual Gross Margin

2.45%
APM annual gross profit margin is 2.45%

Annual Operating Profit

-$10.72 M
APM annual operating income is -$10.72 million

Annual Operating Margin

-2486.05%
APM annual operating profit margin is -2486.05%

Annual Net Income

-$2.82 M
APM annual net profit is -$2.82 million

Annual Net Margin

-654.80%
APM annual net profit margin is -654.80%

EPS

Annual EPS

-$0.62
APM annual earnings per share is -$0.62

Annual EPS Analysts Estimate

-
APM annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+77.45%
APM annual earnings per share is up +77.45% year-on-year

Annual EPS Sector Rank

68.15%
APM annual earnings per share is higher than 68.15% of companies in Healthcare sector

ROA & ROE

Annual ROA

-13.61%
APM annual return on assets is -13.61%

Annual ROE

-24.33%
APM annual return on equity is -24.33%

EBIT & EBITDA

Annual EBIT

-$10.72 M
APM annual earnings before interest & taxes is -$10.72 million

Annual EBITDA

-$9.60 M
APM annual EBITDA is -$9.60 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
APM price to earnings ratio value is unknown

PE Ratio Sector Rank

-
APM price to earnings ratio is unknown

PB Ratio

PB Ratio

0.24
APM price to book ratio is 0.24

PB Ratio Sector Rank

19.83%
APM price to book ratio is higher than 19.83% of companies in Healthcare sector

PS Ratio

PS Ratio

-
APM price to sales ratio value is unknown

PS Ratio Sector Rank

-
APM price to sales ratio is unknown

Enterprise value

Enterprise Value

$7.85 M
APM enterprise value is $7.85 million

Enterprise Value Sector Rank

21.78%
APM enterprise value is higher than 21.78% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
APM EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
APM EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.18
APM annual current ratio is 1.18

Annual Quick Ratio

1.18
APM annual quick ratio is 1.18

Leverage

Annual Debt To Equity

0.12
APM annual debt to equity ratio is 0.12

Annual Interest Coverage Ratio

-
APM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
APM piotroski f-score value is unknown

Altman Z-Score

-5.69
APM altman z-score is -5.69

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$20.64 M
APM annual total assets is $20.64 million

Annual Non Current Assets

$18.16 M
APM annual long term assets is $18.16 million

Annual Current Assets

$2.48 M
APM annual total current assets is $2.48 million

Annual Cash & Cash Equivalents

$2.01 M
APM annual cash & cash equivalents is $2.01 million

Equity

Annual Book Value

$24.85 M
APM annual book value is $24.85 million

Annual Working Capital

$377.30 K
APM annual working capital is $377.30 thousand

Liabilities

Annual Total Liabilities

$5.26 M
APM annual total liabilities is $5.26 million

Annual Total Long Term Liabilities

$3.16 M
APM annual total long term liabilities is $3.16 million

Annual Current Liabilities

$2.10 M
APM annual total current liabilities is $2.10 million

Annual Accounts Payable

-
APM annual accounts payable value is unknown

Debt

Annual Total Debt

$3.28 M
APM annual total debt is $3.28 million

Annual Total Debt 1-Year Change

-52.1%
APM annual total debt is down -52.1% year-on-year

Annual Long Term Debt

$3.16 M
APM annual long term debt is $3.16 million

Annual Short Term Debt

$125.20 K
APM annual short term debt is $125.20 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$11.16 M
APM annual total expenses is $11.16 million

Annual Operating Expenses

$10.73 M
APM annual total operating expenses is $10.73 million

Annual Cost Of Goods Sold

$420.80 K
APM annual cost of goods sold is $420.80 thousand

Annual SGA

$4.42 M
APM annual SGA is $4.42 million

Annual D&A

$1.13 M
APM annual depreciation & amortization is $1.13 million

Annual Interest Expense

-
APM annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$7.72 M
APM annual cash flow from operations is -$7.72 million

Annual CFO 1-Year Change

+37.3%
APM annual cash flow from operations is up +37.3% year-on-year

Annual CFI

$624.80 K
APM annual cash flow from investing activities is $624.80 thousand

Annual CFI 1-Year Change

-74.44%
APM annual cash flow from investing activities is down -74.44% year-on-year

Annual CFF

$4.09 M
APM annual cash flow from financing activities is $4.09 million

Annual CFF 1-Year Change

-38.24%
APM annual cash flow from financing activities is down -38.24% year-on-year

Free CashFlow

Annual FCF

-$7.73 M
APM annual free cash flow is -$7.73 million

Annual FCF 1-Year Change

+38.21%
APM annual free cash flow is up +38.21% year-on-year

CAPEX

Annual CAPEX

$3000.00
APM annual capital expenditures is $3000.00

Annual CAPEX 1-Year Change

-98.39%
APM annual capital expenditures is down -98.39% year-on-year

Institutional Ownership

Similar stocks

APVO logo
Aptevo Therapeutics (APVO)
NUWE logo
Nuwellis (NUWE)
LIFW logo
MSP Recovery (LIFW)
XWEL logo
XWELL (XWEL)
Azitra (AZTR)
LMDX logo
LumiraDx Limited (LMDX)
GTBP logo
GT Biopharma (GTBP)
FRTX logo
Fresh Tracks Therapeutics (FRTX)
NSTG logo
NanoString Technologies (NSTG)

FAQ

  • What is the ticker symbol for Aptorum Group Limited?
  • Does Aptorum Group Limited pay dividends?
  • What sector is Aptorum Group Limited in?
  • What industry is Aptorum Group Limited in?
  • What country is Aptorum Group Limited based in?
  • When did Aptorum Group Limited go public?
  • Is Aptorum Group Limited in the S&P 500?
  • Is Aptorum Group Limited in the NASDAQ 100?
  • Is Aptorum Group Limited in the Dow Jones?
  • When was Aptorum Group Limited's last earnings report?
  • When does Aptorum Group Limited report earnings?
  • Should I buy Aptorum Group Limited stock now?

What is the ticker symbol for Aptorum Group Limited?

The ticker symbol for Aptorum Group Limited is NASDAQ:APM

Does Aptorum Group Limited pay dividends?

No, Aptorum Group Limited does not pay dividends

What sector is Aptorum Group Limited in?

Aptorum Group Limited is in the Healthcare sector

What industry is Aptorum Group Limited in?

Aptorum Group Limited is in the Biotechnology industry

What country is Aptorum Group Limited based in?

Aptorum Group Limited is headquartered in United Kingdom

When did Aptorum Group Limited go public?

Aptorum Group Limited's initial public offering (IPO) was on December 18, 2018

Is Aptorum Group Limited in the S&P 500?

No, Aptorum Group Limited is not included in the S&P 500 index

Is Aptorum Group Limited in the NASDAQ 100?

No, Aptorum Group Limited is not included in the NASDAQ 100 index

Is Aptorum Group Limited in the Dow Jones?

No, Aptorum Group Limited is not included in the Dow Jones index

When was Aptorum Group Limited's last earnings report?

Aptorum Group Limited's most recent earnings report was on Dec 20, 2024

When does Aptorum Group Limited report earnings?

The next expected earnings date for Aptorum Group Limited is Apr 30, 2025

Should I buy Aptorum Group Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions